文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

BRCA1/2 阴性、端粒较短的乳腺癌家系中端粒基因的突变分析。

Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres.

机构信息

Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.

出版信息

Breast Cancer Res Treat. 2012 Aug;134(3):1337-43. doi: 10.1007/s10549-012-2141-2. Epub 2012 Jul 3.


DOI:10.1007/s10549-012-2141-2
PMID:22752289
Abstract

A majority of the familial breast cancer cases are not explained by mutations in the best-known high susceptibility genes BRCA1 and BRCA2. Since there is a link between DNA repair and telomere maintenance mechanisms, we have investigated for the first time the role of telomere genes in breast cancer predisposition. By a combination of DHPLC and direct sequencing, we screened for sequence variation in 14 telomere-related genes which included telomerase and shelterin complexes in index cases from 50 BRCA1/2-negative families previously characterized to have very short telomere length in peripheral blood leukocytes. Clear pathogenic changes were not detected in any of the genes analyzed. Most of the changes were non-coding variants and only nine corresponded to coding variants located in TPP1, TINF2, NHP2, TNKS, and RAD54B genes; although only two corresponded to coding missense changes leading to aminoacid changes in genes NHP2 and RAD54B. However, functional prediction analysis and control population studies of both variants ruled out its possible pathogenic role. Our results discard a major contribution of telomere-specific genes in hereditary breast cancer.

摘要

大多数家族性乳腺癌病例不能用最著名的高易感性基因 BRCA1 和 BRCA2 的突变来解释。由于 DNA 修复和端粒维持机制之间存在联系,我们首次研究了端粒基因在乳腺癌易感性中的作用。通过 DHPLC 和直接测序的组合,我们对 14 个端粒相关基因进行了筛选,这些基因包括端粒酶和庇护复合物,在先前已确定外周血白细胞端粒长度非常短的 50 个 BRCA1/2 阴性家族的指数病例中进行了筛选。在分析的所有基因中均未发现明显的致病性变化。大多数变化是非编码变体,只有 9 个对应于编码变体,位于 TPP1、TINF2、NHP2、TNKS 和 RAD54B 基因中;尽管只有两个对应于编码错义变化,导致基因 NHP2 和 RAD54B 中的氨基酸变化。然而,对这两种变体的功能预测分析和对照人群研究排除了其可能的致病性作用。我们的结果排除了端粒特异性基因在遗传性乳腺癌中的主要作用。

相似文献

[1]
Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres.

Breast Cancer Res Treat. 2012-7-3

[2]
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.

Hum Mutat. 2003-8

[3]
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

Breast Cancer Res Treat. 2004-11

[4]
[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].

Bull Cancer. 2006-9

[5]
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.

Breast Cancer Res Treat. 2010-12-29

[6]
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

Breast Cancer Res Treat. 2009-5

[7]
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.

Breast Cancer Res Treat. 2006-1

[8]
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.

Hum Mutat. 2000-12

[9]
Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.

Breast Cancer Res Treat. 2013-9-15

[10]
Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.

Neoplasma. 2006

引用本文的文献

[1]
NHP2 and PRPF4 are hub genes associated with the prognosis of colorectal cancer.

BMC Cancer. 2025-7-1

[2]
Regulatory roles of RNA modifications in breast cancer.

NAR Cancer. 2021-9-16

[3]
Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.

J Transl Med. 2021-6-30

[4]
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma.

Int J Genomics. 2018-8-19

[5]
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.

Genes Chromosomes Cancer. 2013-4-30

[6]
The complex genetic landscape of familial breast cancer.

Hum Genet. 2013-4-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索